ArticleSensors (Basel, Switzerland)2026
Real-Time WBAN Monitoring: An Adaptive Framework for Selective Signal Restoration and Physiological Trend Prediction.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wireless Body Area Networks (WBANs) enable real-time health monitoring essential for timely clinical intervention, yet their performance is frequently hindered by sensor degradation, noise interference, and strict low-latency constraints in resource-limited environments. Conventional preprocessing approaches indiscriminately reprocess all incoming data, including uncorrupted samples, thereby increasing computational overhead, introducing latency, and potentially distorting valid physiological trends. This study introduces a unified real-time monitoring framework tailored for WBAN systems. The key contributions include: (1) an adaptively gated multi-stage preprocessing pipeline that selectively restores corrupted samples while preserving clean data, (2) an overlap-aware sliding-window mechanism enabling low-latency operation, and (3) a clinically informed risk assessment strategy for early-warning support. By avoiding unnecessary modification of intact signals, the framework maintains physiological integrity while substantially improving reconstruction and predictive reliability. Across multiple vital signs, the proposed approach achieves substantial reconstruction gains, with Mean Squared Error (MSE) reductions ranging from 53% to 67% under strong degradation conditions. An adaptive ARIMA-based forecasting layer captures short-term physiological dynamics with directional accuracies of approximately 65-70% for one-step (10 s) ahead prediction. Early-warning behavior is intentionally conservative, prioritizing false alarm suppression over aggressive alerting. Per-signal evaluation reveals high sensitivity for blood pressure signals, whereas glucose and certain high-variability modalities exhibit conservative sensitivity under modality-specific thresholds. Importantly, the aggregated multi-modal risk decision achieves strong overall system-level performance, with sensitivity and specificity of 0.89 and 0.92, respectively. Overall, the proposed framework establishes a robust, low-latency, and computationally efficient foundation for dependable physiological monitoring in WBAN environments, leveraging selective processing to optimize both resource utilization and clinical reliability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.